Skip to main
GEHC

GEHC Stock Forecast & Price Target

GEHC Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 31%
Buy 31%
Hold 31%
Sell 0%
Strong Sell 8%

Bulls say

GE HealthCare Technologies demonstrates a strong growth outlook, supported by key performance metrics such as organic order growth of 2% year-over-year, a book-to-bill ratio of 1.06x, and a significant backlog growth of 10% year-over-year, providing visibility for future sales. The company's nearly $20 billion backlog, coupled with increasing capital spending expectations from hospital customers, positions GEHC favorably for sustained market demand in the coming years. Furthermore, ongoing margin improvement initiatives and a strategic focus on high-growth areas, including pharmaceutical diagnostics and digital innovations, enhance the potential for revenue growth and profitability enhancement.

Bears say

The financial outlook for GE HealthCare Technologies is negatively impacted by several key factors, including increasing competition in its highly competitive markets and ongoing supply chain risks that could disrupt manufacturing and fulfillment capabilities. The company faces additional challenges from a challenging macroeconomic environment that adversely affects capital purchasing patterns in hospitals and may result in declining demand for its solutions. Furthermore, potential issues related to unsuccessful acquisition integrations and slower adoption of new product introductions pose significant risks to future growth and market share retention.

GEHC has been analyzed by 13 analysts, with a consensus rating of Buy. 31% of analysts recommend a Strong Buy, 31% recommend Buy, 31% suggest Holding, 0% advise Selling, and 8% predict a Strong Sell.

This aggregate rating is based on analysts' research of GE HealthCare Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About GE HealthCare Technologies Inc (GEHC) Forecast

Analysts have given GEHC a Buy based on their latest research and market trends.

According to 13 analysts, GEHC has a Buy consensus rating as of Apr 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $88.77, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $88.77, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

GE HealthCare Technologies Inc (GEHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.